Cargando…

Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against Clostridium perfringens in an intestinal infection model

This study aimed to evaluate the antibacterial activity of isopropoxy benzene guanidine (IBG) against C. perfringens based on pharmacokinetics/pharmacodynamics (PK/PD) modeling in broilers. The PK parameters of IBG in the plasma and ileal content of C. perfringens-infected broilers following oral ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yixing, Yang, Liuye, Zhang, Wanying, Li, Jie, Peng, Xianfeng, Qin, Zonghua, Zeng, Zhenling, Zeng, Dongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557049/ https://www.ncbi.nlm.nih.gov/pubmed/36246309 http://dx.doi.org/10.3389/fvets.2022.1004248

Ejemplares similares

Pharmacokinetics and Pharmacodynamics of Colistin Combined With Isopropoxy Benzene Guanidine Against mcr-1-Positive Salmonella in an Intestinal Infection Model
por: Kong, Lingli, et al.
Publicado: (2022)

Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin
por: Lu, Yixing, et al.
Publicado: (2022)

Isopropoxy Benzene Guanidine Kills Staphylococcus aureus Without Detectable Resistance
por: Zhang, Xiufeng, et al.
Publicado: (2021)

Metabolite Identification of Isopropoxy Benzene Guanidine in Rat Liver Microsomes by Using UHPLC-Q-TOF-MS/MS
por: Lu, Yixing, et al.
Publicado: (2023)

In vitro Antibacterial Activity of Isopropoxy Benzene Guanidine Against Multidrug-Resistant Enterococci
por: Zhang, Xiufeng, et al.
Publicado: (2019)

Isopropoxy Benzene Guanidine Ameliorates Streptococcus suis Infection In Vivo and In Vitro
por: Han, Ning, et al.
Publicado: (2023)

Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens
por: Li, Jie, et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine
por: Yan, Lei, et al.
Publicado: (2017)

Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats
por: Xie, Shiting, et al.
Publicado: (2023)

Effect of Porcine Clostridium perfringens on Intestinal Barrier, Immunity, and Quantitative Analysis of Intestinal Bacterial Communities in Mice
por: Jiang, Zipeng, et al.
Publicado: (2022)

Dietary Lactobacillus fermentum and Lactobacillus paracasei improve the intestinal health of broilers challenged with coccidia and Clostridium perfringens
por: Li, Peng, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model
por: Zeng, Dongping, et al.
Publicado: (2018)

Dietary Lactobacillus fermentum and Bacillus coagulans Supplementation Modulates Intestinal Immunity and Microbiota of Broiler Chickens Challenged by Clostridium perfringens
por: Guo, Shuangshuang, et al.
Publicado: (2021)

Antimicrobial susceptibility of Clostridium perfringens strains isolated from broiler chickens
por: Silva, R. O. S., et al.
Publicado: (2009)

Antimicrobial susceptibility of Clostridium perfringens isolated from piglets with or without diarrhea in Brazil
por: Salvarani, Felipe Masiero, et al.
Publicado: (2012)

Infection Dynamics of Clostridium perfringens Fingerprinting in Buffalo and Cattle of Punjab Province, Pakistan
por: Zafar Khan, Muhammad Umar, et al.
Publicado: (2022)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
por: Zhang, Longfei, et al.
Publicado: (2022)

First molecular evidence of Clostridium perfringens in adult Fasciola spp. isolates in cattle hosts
por: Karagulle, Burcu, et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
por: Olivarez, Jeff D., et al.
Publicado: (2023)

Dietary Antibiotic Growth Promoters Down-Regulate Intestinal Inflammatory Cytokine Expression in Chickens Challenged With LPS or Co-infected With Eimeria maxima and Clostridium perfringens
por: Oh, Sungtaek, et al.
Publicado: (2019)

A lytic bacteriophage isolate reduced Clostridium perfringens induced lesions in necrotic enteritis challenged broilers
por: Keerqin, Chake, et al.
Publicado: (2022)

Nectarivorous Bird Emphysematous Ingluvitis (NBEI): A Novel Disease in Loriinae Birds Associated With Clostridium perfringens Infection
por: Rich, Andrew F., et al.
Publicado: (2020)

Antimicrobial susceptibility and multilocus sequence typing of Clostridium perfringens isolated from yaks in Qinghai-Tibet plateau, China
por: Wu, Dan, et al.
Publicado: (2022)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
por: Smith, Joe S., et al.
Publicado: (2023)

Clostridium perfringens Types A and D Involved in Peracute Deaths in Goats Kept in Cholistan Ecosystem During Winter Season
por: Hussain, Riaz, et al.
Publicado: (2022)

Pharmacokinetic–Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers
por: Sang, KaNa, et al.
Publicado: (2016)

Clostridium perfringens Delta-Toxin Damages the Mouse Small Intestine
por: Seike, Soshi, et al.
Publicado: (2019)

Presence and molecular characterization of Clostridium difficile and Clostridium perfringens in intestinal compartments of healthy horses
por: Schoster, Angelika, et al.
Publicado: (2012)

Pathogenicity and virulence of Clostridium perfringens
por: Mehdizadeh Gohari, Iman, et al.
Publicado: (2021)

The Effect of a Modified GH11 Xylanase on Live Performance, Gut Health, and Clostridium perfringens Excretion of Broilers Fed Corn-Soy Diets
por: Nusairat, Basheer, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum
por: Xiao, Xia, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of an Oral Formulation of Apixaban in Horses After Oral and Intravenous Administration
por: Serpa, Priscila B. S., et al.
Publicado: (2018)

Tissue Residues and Pharmacokinetic/Pharmacodynamic Modeling of Tiamulin Against Mycoplasma anatis in Ducks
por: Elazab, Sara T., et al.
Publicado: (2020)

Clostridium perfringens Sialidases: Potential Contributors to Intestinal Pathogenesis and Therapeutic Targets
por: Li, Jihong, et al.
Publicado: (2016)

Characterization of intestinal immune response to Clostridium perfringens infection in broiler chickens
por: Fasina, Yewande O, et al.
Publicado: (2019)

miR-30d Inhibition Protects IPEC-J2 Cells Against Clostridium perfringens Beta2 Toxin-Induced Inflammatory Injury
por: Xie, Kaihui, et al.
Publicado: (2022)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2020)

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Immediate- and Modified-Release Mycophenolic Acid Preparations in Healthy Beagle Dogs
por: Klotsman, Michael, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens
por: Zhang, Nan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m3ufp4927rdd06uqte6ub1ib05